Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | dihydrofolate reductase | 0.0048 | 0.0445 | 0.0649 |
Mycobacterium ulcerans | DNA polymerase IV | 0.0019 | 0.0061 | 0.0047 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0019 | 0.0061 | 0.0009 |
Brugia malayi | thymidylate synthase | 0.0119 | 0.1355 | 1 |
Mycobacterium tuberculosis | Possible DNA-damage-inducible protein P DinP (DNA polymerase V) (pol IV 2) (DNA nucleotidyltransferase (DNA-directed)) | 0.0019 | 0.0061 | 0.0047 |
Toxoplasma gondii | bifunctional dihydrofolate reductase-thymidylate synthase | 0.0167 | 0.1982 | 1 |
Leishmania major | DNA polymerase eta, putative | 0.0019 | 0.0061 | 0.0009 |
Leishmania major | thymidine kinase, putative | 0.0533 | 0.6713 | 1 |
Leishmania major | dihydrofolate reductase-thymidylate synthase | 0.0167 | 0.1982 | 0.2895 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0019 | 0.0061 | 0.0009 |
Echinococcus multilocularis | lamin dm0 | 0.0026 | 0.0157 | 0.0103 |
Echinococcus multilocularis | terminal deoxycytidyl transferase rev1 | 0.0019 | 0.0061 | 0.0006 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0019 | 0.0061 | 0.0009 |
Trichomonas vaginalis | thymidine kinase, putative | 0.0533 | 0.6713 | 1 |
Echinococcus multilocularis | transfer RNA-Ile | 0.0483 | 0.6068 | 0.6046 |
Echinococcus granulosus | lamin | 0.0026 | 0.0157 | 0.017 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0019 | 0.0061 | 0.0009 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0019 | 0.0061 | 0.0009 |
Giardia lamblia | Deoxynucleoside kinase | 0.0385 | 0.4797 | 0.7123 |
Brugia malayi | dihydrofolate reductase family protein | 0.0048 | 0.0445 | 0.3285 |
Brugia malayi | hypothetical protein | 0.0057 | 0.055 | 0.4056 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0019 | 0.0061 | 0.0009 |
Mycobacterium ulcerans | DNA polymerase IV | 0.0019 | 0.0061 | 0.0047 |
Echinococcus granulosus | thymidine kinase | 0.0483 | 0.6068 | 1 |
Trichomonas vaginalis | DNA polymerase IV / kappa, putative | 0.0019 | 0.0061 | 0.0009 |
Mycobacterium tuberculosis | Hypothetical protein | 0.0057 | 0.055 | 0.3805 |
Loa Loa (eye worm) | hypothetical protein | 0.0026 | 0.0151 | 0.1114 |
Echinococcus granulosus | terminal deoxycytidyl transferase rev1 | 0.0019 | 0.0061 | 0.001 |
Schistosoma mansoni | lamin | 0.0026 | 0.0157 | 0.017 |
Mycobacterium tuberculosis | Conserved hypothetical protein | 0.0019 | 0.0061 | 0.0047 |
Giardia lamblia | DINP protein human, muc B family | 0.0019 | 0.0061 | 0.0009 |
Echinococcus granulosus | dna polymerase kappa | 0.0019 | 0.0061 | 0.001 |
Loa Loa (eye worm) | hypothetical protein | 0.0026 | 0.0157 | 0.116 |
Schistosoma mansoni | bifunctional dihydrofolate reductase-thymidylate synthase | 0.0119 | 0.1355 | 0.2163 |
Echinococcus granulosus | thymidine kinase | 0.0483 | 0.6068 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0019 | 0.0061 | 0.0009 |
Brugia malayi | Intermediate filament tail domain containing protein | 0.0026 | 0.0157 | 0.116 |
Loa Loa (eye worm) | intermediate filament tail domain-containing protein | 0.0026 | 0.0157 | 0.116 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0019 | 0.0061 | 0.0009 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0019 | 0.0061 | 0.0009 |
Loa Loa (eye worm) | intermediate filament protein | 0.0026 | 0.0157 | 0.116 |
Mycobacterium tuberculosis | Dihydrofolate reductase DfrA (DHFR) (tetrahydrofolate dehydrogenase) | 0.0048 | 0.0445 | 0.3002 |
Entamoeba histolytica | thymidine kinase, putative | 0.0533 | 0.6713 | 1 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0019 | 0.0061 | 0.0009 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.0061 | 0.0449 |
Leishmania major | DNA polymerase kappa, putative | 0.0019 | 0.0061 | 0.0009 |
Echinococcus granulosus | thymidylate synthase | 0.0119 | 0.1355 | 0.2163 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0019 | 0.0061 | 0.0009 |
Schistosoma mansoni | thymidine kinase | 0.0483 | 0.6068 | 1 |
Loa Loa (eye worm) | thymidylate synthase | 0.0119 | 0.1355 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0019 | 0.0061 | 0.0009 |
Echinococcus granulosus | lamin dm0 | 0.0026 | 0.0157 | 0.017 |
Schistosoma mansoni | lamin | 0.0026 | 0.0157 | 0.017 |
Trypanosoma cruzi | dihydrofolate reductase-thymidylate synthase, putative | 0.0057 | 0.055 | 0.0743 |
Trypanosoma brucei | unspecified product | 0.0019 | 0.0061 | 0.0009 |
Trichomonas vaginalis | DNA polymerase eta, putative | 0.0019 | 0.0061 | 0.0009 |
Schistosoma mansoni | intermediate filament proteins | 0.0026 | 0.0157 | 0.017 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0019 | 0.0061 | 0.0009 |
Trypanosoma cruzi | thymidine kinase, putative | 0.0533 | 0.6713 | 1 |
Trichomonas vaginalis | thymidine kinase, putative | 0.0533 | 0.6713 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0019 | 0.0061 | 0.0009 |
Trypanosoma cruzi | thymidine kinase, putative | 0.0533 | 0.6713 | 1 |
Brugia malayi | intermediate filament protein | 0.0026 | 0.0157 | 0.116 |
Brugia malayi | Dihydrofolate reductase | 0.0048 | 0.0445 | 0.3285 |
Chlamydia trachomatis | dihydrofolate reductase | 0.0048 | 0.0445 | 0.5 |
Plasmodium vivax | bifunctional dihydrofolate reductase-thymidylate synthase, putative | 0.0167 | 0.1982 | 1 |
Brugia malayi | ImpB/MucB/SamB family protein | 0.0019 | 0.0061 | 0.0449 |
Treponema pallidum | exodeoxyribonuclease (exoA) | 0.0018 | 0.0055 | 0.5 |
Leishmania major | DNA polymerase kappa, putative,DNA polymerase IV, putative | 0.0019 | 0.0061 | 0.0009 |
Echinococcus multilocularis | thymidine kinase | 0.0483 | 0.6068 | 0.6046 |
Trypanosoma brucei | thymidine kinase | 0.0533 | 0.6713 | 1 |
Schistosoma mansoni | dihydrofolate reductase | 0.0048 | 0.0445 | 0.0649 |
Echinococcus multilocularis | dihydrofolate reductase | 0.0048 | 0.0445 | 0.0393 |
Schistosoma mansoni | DNA polymerase eta | 0.0019 | 0.0061 | 0.001 |
Schistosoma mansoni | rab geranylgeranyl transferase alpha subunit | 0.0019 | 0.0061 | 0.001 |
Loa Loa (eye worm) | ImpB/MucB/SamB family protein | 0.0019 | 0.0061 | 0.0449 |
Echinococcus multilocularis | thymidine kinase | 0.0483 | 0.6068 | 0.6046 |
Loa Loa (eye worm) | exodeoxyribonuclease III family protein | 0.0018 | 0.0055 | 0.0404 |
Loa Loa (eye worm) | dihydrofolate reductase | 0.0048 | 0.0445 | 0.3285 |
Echinococcus granulosus | Thymidine kinase 2 mitochondrial | 0.0483 | 0.6068 | 1 |
Echinococcus multilocularis | thymidylate synthase | 0.0119 | 0.1355 | 0.1308 |
Mycobacterium tuberculosis | Probable thymidylate synthase ThyA (ts) (TSASE) | 0.0119 | 0.1355 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0057 | 0.055 | 0.0743 |
Echinococcus granulosus | dna polymerase eta | 0.0019 | 0.0061 | 0.001 |
Echinococcus multilocularis | lamin | 0.0026 | 0.0157 | 0.0103 |
Trypanosoma cruzi | dihydrofolate reductase-thymidylate synthase | 0.0167 | 0.1982 | 0.2895 |
Trypanosoma cruzi | DNA polymerase eta, putative | 0.0019 | 0.0061 | 0.0009 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0019 | 0.0061 | 0.0009 |
Echinococcus multilocularis | musashi | 0.0026 | 0.0157 | 0.0103 |
Mycobacterium ulcerans | thymidylate synthase | 0.0119 | 0.1355 | 1 |
Entamoeba histolytica | deoxycytidyl transferase, putative | 0.0019 | 0.0061 | 0.0009 |
Trypanosoma brucei | dihydrofolate reductase-thymidylate synthase | 0.0167 | 0.1982 | 0.2895 |
Wolbachia endosymbiont of Brugia malayi | exonuclease III | 0.0018 | 0.0055 | 0.5 |
Trypanosoma brucei | DNA polymerase eta, putative | 0.0019 | 0.0061 | 0.0009 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0019 | 0.0061 | 0.0009 |
Onchocerca volvulus | 0.0119 | 0.1355 | 1 | |
Brugia malayi | exodeoxyribonuclease III family protein | 0.0018 | 0.0055 | 0.0404 |
Mycobacterium leprae | PROBABLE THYMIDYLATE SYNTHASE THYA (TS) (TSASE) | 0.0119 | 0.1355 | 1 |
Brugia malayi | ImpB/MucB/SamB family protein | 0.0019 | 0.0061 | 0.0449 |
Giardia lamblia | Thymidine kinase | 0.0533 | 0.6713 | 1 |
Echinococcus multilocularis | dna polymerase kappa | 0.0019 | 0.0061 | 0.0006 |
Echinococcus multilocularis | dna polymerase eta | 0.0019 | 0.0061 | 0.0006 |
Schistosoma mansoni | terminal deoxycytidyl transferase | 0.0019 | 0.0061 | 0.001 |
Trichomonas vaginalis | thymidine kinase, putative | 0.0533 | 0.6713 | 1 |
Mycobacterium ulcerans | dihydrofolate reductase DfrA | 0.0048 | 0.0445 | 0.3002 |
Echinococcus granulosus | intermediate filament protein | 0.0026 | 0.0157 | 0.017 |
Plasmodium falciparum | bifunctional dihydrofolate reductase-thymidylate synthase | 0.0167 | 0.1982 | 1 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0019 | 0.0061 | 0.0009 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
ED50 (functional) | = 17 uM | Evaluated for antiparasitic activity against brucei trypomastigotes | ChEMBL. | 10821719 |
ED50 (functional) | = 17 uM | Evaluated for antiparasitic activity against brucei trypomastigotes | ChEMBL. | 10821719 |
ID50 (functional) | = 1.26 uM | Tested for cytotoxicty in human K562 cells | ChEMBL. | 10821719 |
ID50 (functional) | = 1.26 uM | Tested for cytotoxicty in human K562 cells | ChEMBL. | 10821719 |
Inhibition (functional) | % | Compound is evaluated for antiparasitic activity against Leishmania donovani;T/100, toxic to macrophages/100% inhibition of parasites | ChEMBL. | 10821719 |
Inhibition (functional) | % | Compound is evaluated for antiparasitic activity against Trypanosoma cruzi;T/100, toxic to macrophages/100% inhibition of parasites | ChEMBL. | 10821719 |
Inhibition (functional) | 0 % | Compound is evaluated for antiparasitic activity against Leishmania donovani;T/100, toxic to macrophages/100% inhibition of parasites | ChEMBL. | 10821719 |
Inhibition (functional) | 0 % | Compound is evaluated for antiparasitic activity against Trypanosoma cruzi;T/100, toxic to macrophages/100% inhibition of parasites | ChEMBL. | 10821719 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.